Know Cancer

or
forgot password

Phase II Study to Evaluate Efficacy and Safety of Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Patients With Nasopharyngeal Carcinoma


Phase 2
18 Years
80 Years
Not Enrolling
Both
Nasopharyngeal Carcinoma

Thank you

Trial Information

Phase II Study to Evaluate Efficacy and Safety of Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Patients With Nasopharyngeal Carcinoma


Inclusion Criteria:



Age≥18,T1-2aN1-3;T2-4NxNPC,VEGFR+,++,KPS＞70,Life expectancy≥6 months, No uncontrolled
hypertension,cardiac failure,diabetes,lunacy

Exclusion Criteria:

Distant metastasis, recurrent disease

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

locoregionally control rate

Outcome Description:

3 months after treatment

Outcome Time Frame:

3 months

Safety Issue:

No

Authority:

China: Food and Drug Administration

Study ID:

Daping H 001

NCT ID:

NCT01265147

Start Date:

January 2011

Completion Date:

December 2017

Related Keywords:

  • Nasopharyngeal Carcinoma
  • Carcinoma
  • Nasopharyngeal Neoplasms

Name

Location